1Kessler RC,Berglund P,Demler O,et al.The epidemiology of major depressive disorder-Results from the National Comorbidity Survey Replication (NCS-R)[J].Jama-J Am Med Assoc,2003,289(23):3095 -3105. 被引量：1
2Khan A.Vilazodone,a novel dual -acting serotonergic antidepressant for managing major depression[J].Expert Opinion on Investigational Drugs,2009,18(11):1753-1764. 被引量：1
3BanasrM,SoumierA,HeryM.Agomelatine,a new antidep ressant,induces regional changes in hippocampal neurogenesis[J].Biol Psychiatry,2006,59(11):1087. 被引量：1
4Lam RW,Hossie H,Solomons K,Yatham LN.Citalopram and bupropion-SR:Combining versus switching in patients with treatment-resistant depression[J].Journal of Clinical Psychiatry,2004,65(3):337 -340. 被引量：1
5Skolnick P,Krieter P,Tizzano J,et al.Preclinical and clinical pharmacology of DOV 216,303,a "triple" reuptake inhibitor[J].Cns Drug Reviews,2006,12(2):123-134. 被引量：1
6Sapolsky RM.The possibility of neurotoxicity in the hippocampus in major depression:A primer on neuron death[J].Biological Psychiatry,2000,48(8):755 -765. 被引量：1
7Berman RM,Cappiello A,Anand A,et al.Antidepressant effects of ketamine in depressed patients[J].Biological Psychiatry,2000,47(4):351-354. 被引量：1
8Tsai SJ.The possible role of tissue-type plasminogen activator and the plasminogen system in the pathogenesis of major depression[J].Medical Hypotheses,2006,66(2):319 -322. 被引量：1
9Layer RT,Popik P,Olds T,et al.Antidepressant-like actions of the polyamine site NMDA antagonist,Eliprodil (SL -82.0715)[J].Pharmacology Biochemistry and Behavior,1995,52 (3):621-627. 被引量：1
10Li X,Tizzano JP,Griffey K,et al.Antidepressant-like actions of an AMPA receptor potentiator (LY392098)[J].Neuropharmacology,2001,40 (8):1028-1033. 被引量：1
